Trombosis del seno venoso transverso en un paciente con cefalea tipo migraña: reporte de caso y revisión de la literatura
Barra lateral del artículo
Descargas
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Contenido principal del artículo
Resumen
La trombosis de senos venosos cerebrales es una enfermedad de difícil diagnóstico por la variabilidad de sus presentaciones clínicas. Es una causa poco común de infarto cerebral, si se le compara con el infarto de origen arterial. Tiene una gran morbilidad y puede causar la muerte en 10% de los pacientes. Se describe el caso clínico de una paciente con cefalea tipo migraña con aura, en terapia con anticonceptivos orales combinados desde hacía tres meses, que consulta por una crisis inusual de su migraña, en quien, por angioresonancia contrastada cerebral, se hace diagnóstico de trombosis de seno transverso izquierdo. Se inició tratamiento anticoagulante con heparina de bajo peso molecular con evolución favorable y se remite a valoración por Ginecología para establecer tratamiento de ovario poliquístico. A propósito de este caso, se ha hecho una revisión del tema junto con el enfoque diagnóstico y tratamiento de la trombosis venosa cerebral y su asociación con la migraña.
Citas
Bajwa ZH, Sabahat A. Pathophysiology, clinical manifestations and diagnosis of migraine adults [Internet]. Waltham, MA: Up To Date; 2007 [acceso 10 de octubre de 2007]. Disponible en: http://www. uptodate.com/online
Paradowski B, Koziorowska E, Kowalczyk E, Kwiatkowska W, Sąsiadek M. Diagnostic difficulties in cerebral venous thrombosis.Case Rep Clin Pract Rev.2006;7:132-34.
Einhaupl KM, Masuhr F. Cerebral sinus and venous thrombosis. Ther Umsch.1996;53(7): 552-8.
Smith R, Hourihan MD. Investigating suspected cerebral venous thrombosis.BMJ.2007;334: 794-95
Tsai FY, Kostanian V, Rivera M, Kwo LW, Chen CC, Nguyen TH. Cerebral venous congestion as indication for thrombolytic treatment.Cardiovasc Intervent Radiol.2007;30:675-87.
Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000;76(891): 12-5.
Bressler R, Durand JL. Oral contraceptive risks: a realistic appraisal. Drug Ther (NY).1979;9(10):81-95.
Canhao P, Ferro JM, Lindgren AG, Bousser MG, Bouser MG, Stam J. Causes and predictors of death in cerebral venous thrombosis.Stroke.2005;36(8):1720-5.
Terés NL, Jiménez AJ, Núñez AB, Barrero C, Aguilar JL, Moreno R. Trombosis venosa cerebral. una realidad en urgencias.Emergencias.2007;19:99-103.
Bruijn S, Stam J. Randomized placebo controlled trial of anticoagulant treatment with low molecular weight heparin for cerebral sinus thrombosis. Stroke.1999;30:484–8
Niclot P, Bousser MG. Cerebral venous thrombosis. Curr Treat Options Neurol. 2000;2:343–52.
Biousse V, Newman NJ. Venous disease of the central nervous system. Semin Cerebrovasc Dis Stroke. 2004;4:2-17.
Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-8.
Lancon JA, Killough KR, Tibbs RE, Lewisa AI, Andrew D. Spontaneous dural sinus thrombosis in children. Pediatr Neurosurg.1999;30:23-9.
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke.2004;30(35):664-70.
DeVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417- 23.
Schaller B, Graf R. Cerebral venous infarction: the pathophysiological concept. Cerebrovasc Dis. 2004;18:179-88.
Lövblada KO, Bassettib C, Schneidera J, Guzmana R, Koussya M, Remondaa L, et al. Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis.2001;11:169-76.
Appenzeller S, Zeller CB, Annichino-Bizzachi JM, Costallat LT, Deus-Silva L, Voetsch B, et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg.2005;107:371-78.
Anand N, Chan C, Wang NE .Cerebral venous thrombosis: a case report. J Emerg Med. 2007; 20(10):1-6.
Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry.2005;76 (8):1084-87.
Agostoni E. Headache in cerebral venous thrombosis. Neurol Sci. 2004;25(3):206-10.
Bousser MG. Cerebral venous thrombosis: diagnosis and management.J Neurol. 2000; 247: 252–58.
Selpúlveda JM, Posada IJ, González J, Ramos, A, Bermejo F. Anticoagulación en infartos cerebrales hemorrágicos por extensa trombosis de senos venosos. Neurología.2004;19(10):769-73.
Sánchez JP, Espina RB, Valle SR, Gutiérrez A. Trombosis de los senos venosos cerebrales. Medicine.2003;8:4987-4.
Scutelnicu D, Barsasteanu F. Cerebral thrombosis of the transverse sinus. TMJ. 2003;53(3):267-71.
Mehraeina S, Schmidtkeb K, Villringera A, Valduezaa JM, Masuhra F. Heparin Treatment in Cerebral Sinus and Venous Thrombosis: Patients at Risk of Fatal Outcome. Cerebrovasc Dis. 2003;15:17–21.
Barnwell SL, Higashida RT, Halbach VV, Dowd CF, Hieshima GB. Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery.1991;28:135– 42.
Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK.Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke.1999;30:489–94.
Otrock Z, Taher A, Shamseddeen W, Mahfouz R. Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis. J Thromb Thrombolysis. 2008 Aug;26(1):41-3
Bousser MG. Cerebral venous thrombosis. Nothing, heparin, or local thrombolysis?. Stroke. 1999;30:481– 83.
Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291(4):427- 34.
Jones DH, Warlow CP. The causes of the stroke in the young. J Neurol.2004;232:137-43.
Tietjen GE. The risk of stroke in patients with migraine and implications for migraine management. CNS Drugs.2005;19:683-92.
Teal SB, Ginosar DM. Contraception for women with chronic medical conditions. Obstet Gynecol Clin North Am.2007;34:113-26.
Piero DV, Bonaffini N, Altieri M. Migraine and cerebrovascular disease. J Headache Pain. 2004;5: 78-80.
Agostoni E, Fumagalli L, Santoro P, Ferrarese C. Migraine and stroke. Neurol Sci.2004; 25:123-25.
Allais G, De Lorenzo C, Mana O, Benedetto C. Oral contraceptives in women with migraine: balancing risks and benefits. Neurol Sci.2004;25:211-14.
Parnetti L, Paciaroni M, Gallai V. Headache and ischemic stroke. J Headache Pain. 2004;3:15-20.
Agostoni E, Aliprandi A. The complication of migraine with aura. Neurol Sci. 2006;27:91-95.
Frigerio R, Santoro P, Ferrarese C, Agostoni E. Migrainus cerebral infarction: case reports. Neurol Sci. 2004 Oct;25 Suppl 3:S300-1.
Slooter JC, Ramos MP, Kappelle LJ. Migraine-like headache as the presenting symptom of cerebral venous sinus thrombosis. J Neurol. 2002;249:775–6.
Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary Prevention of Ischemic Stroke. Circulation.2006;113:873-23.
Kurth T. Migraine, headache, and the risk of stroke in women. Neurology.2005;64:1020- 26.
Bousser MG. Estrogens, Migraine and Stroke. Stroke.2004;35:2652-56. 46. Eggers AE. New neural theory of migraine. Med Hypotheses.2001;56(3):360-3.
Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia.2001;21:137– 39.
Welch KM, Brandes AW, Salerno L, Brandes JL. C-Reactive protein may be increased in migraine patients who present wth complex clinical features. Headache.2006;46:197-9.
Moschiano F, D’Amico D, Ciusani E, Erba N, Rigamonti A, Schieroni F, Bussone G. Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke?. Neurol Sci. 2004;25:126–28.
Van Nuenen BF, Munneke M, Bloem BR. Cerebral Venous Sinus Throm- bosis: prevention of recurrent thromboembolism. Stroke.2005;36:1822-3.
Tardy B, Tardy-Poncet B, Viallon A, Piot M, Garnier P, Mohamedi R et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med. 2002;113:238-41.
Kosinski CM, Mull M, Schwarz M, Koch B, Biniek R, Schläfer J, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis?. Stroke. 2004;35:2820- 25.
Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis:review of 38 cases. Stroke.1985;16:199-213.
Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology.1999;53:1537.
Stam J, de Bruijn S, deVeber G. Anticoagulation of cerebral venous thrombosis. Stroke.2003; 34:1054- 1055.
N a g a r a j a D , S a r m a G R . T r e a t m e n t of cerebral sinus/venous thrombosis. Neurol India.2002;50:114-6.
Kimber J. Cerebral venous sinus thrombosis. QJM.2002;95:137-142.
Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991 Sep 7;338(8767):597- 600
De Bruijn SF, Stam J. For the cerebral venous sinus study group: clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry. 2001;70:105–108.